# Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial

> **NCT07734792** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **yifang zhu** · enrollment: 726 (estimated)

## Conditions studied

- Acute Ischemic Stroke (AIS)

## Interventions

- **DRUG:** Tirzepatide
- **OTHER:** Standard Medical Care (SMC)

## Key facts

- **NCT ID:** NCT07734792
- **Lead sponsor:** yifang zhu
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-20
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 726 (ESTIMATED)
- **Last updated:** 2026-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07734792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07734792, "Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07734792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*